NPPB and cardiac hypertrophy: Additionally, an elevated NT-proBNP level persisting after TAVR is likely the result of comprehensive factors, including residual cardiac hypertrophy/fibrosis, impaired cardiac function, volume overload, and other concomitant diseases (29, 30).